<DOC>
	<DOCNO>NCT00214331</DOCNO>
	<brief_summary>This protocol prospective , open-label , multicenter , population pharmacokinetic pharmacodynamic study select anti-infective agent pregnant woman treat suspected documented infection .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Selected Antibiotics During Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Women second third trimester pregnancy Women currently receive treatment whose physician make decision start treatment ciprofloxacin , azithromycin gentamicin suspect documented infection Of childbearing potential either never pregnant whose recent pregnancy end 3 month previously ( control group ) Women great 3 month postpartum currently breastfeed ( substudy ) Women significant gastrointestinal disease may expect interfere absorption orally administer antiinfective agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>